Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Oct 13, 2004

Mylan Responds to Letter from UBS

Oct 05, 2004

Mylan Announces Expiration of Hart-Scott-Rodino Waiting Period for King Acquisition

Sep 29, 2004

Mylan Receives FDA Approval for Bromocriptine Mesylate Tablets

Sep 20, 2004

Mylan Responds to Icahn's 13D Filing

Sep 20, 2004

Mylan Declares Quarterly Cash Dividend

Sep 14, 2004

Mylan Announces Investor Roadshow Regarding the King Acquisition and Update on Nebivolol

Sep 08, 2004

Mylan Responds to Carl Icahn's 13D Filing

Sep 08, 2004

Mylan Lowers Shareholder Rights Plan Threshold From 15% To 10%

Sep 07, 2004

Mylan Completes Next Step in Proposed Acquisition of King Pharmaceuticals with Filing of Form S-4 Registration Statement

Aug 30, 2004

Mylan Withdraws Lawsuit in Order to Consider Additional Authorized Generics Claims

Pagination

First page
Previous page
…
Page 113
Page 114
Page 115
Page 116
Current page 117
Page 118
Page 119
Page 120
Page 121
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2026 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.